<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68FB3A84-29CE-4F10-B27B-1482AD81759C"><gtr:id>68FB3A84-29CE-4F10-B27B-1482AD81759C</gtr:id><gtr:name>Beatson Institute for Cancer Research</gtr:name><gtr:address><gtr:line1>Garscube Estate</gtr:line1><gtr:line2>Switchback Road, Bearsden</gtr:line2><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G61 1BD</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:department>Sch of Biological Sciences</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68FB3A84-29CE-4F10-B27B-1482AD81759C"><gtr:id>68FB3A84-29CE-4F10-B27B-1482AD81759C</gtr:id><gtr:name>Beatson Institute for Cancer Research</gtr:name><gtr:address><gtr:line1>Garscube Estate</gtr:line1><gtr:line2>Switchback Road, Bearsden</gtr:line2><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G61 1BD</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C047998C-37DB-4DCE-98E1-A4BA02F0D930"><gtr:id>C047998C-37DB-4DCE-98E1-A4BA02F0D930</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>Richard</gtr:otherNames><gtr:surname>White</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500346"><gtr:id>923D1246-12A5-4CA3-9B3E-DE4976DA2AA0</gtr:id><gtr:title>Multiparameter imaging of signalling and transcription in mammalian cells</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500346</gtr:grantReference><gtr:abstractText>The ability to present cellular processes in the form of colour pictures and as timelapse videos, offers significant potential for presentation to lay groups. I have taken part in a number of activities that relate to public understanding of Science. These have included lectures at meetings of the British Association for the Advancement of Science (BA), local (Merseyside) and national (Radio 4) radio and television interviews. Our work has regularly attracted considerable positive press publicity locally (Merseyside newspapers), nationally (BBC and national papers) and internationally (e.g. recent interview for New York based Discover magazine). The concept of oscillating signals in cells is both novel and can be translated in simple terms for the public. I take these activities seriously, since our work can give Science and scientists a better profile. I have attended both MRC and BBSRC sessions on dealing with the Press and Public Understanding of Science.
We are generating colour videos and pictures that dramatically show important cellular events. This represents an excellent resource for further developing a programme of lay presentations. I have been approached by a local Merseyside architect, Ken Martin, regarding plans for a movie-based ?art and science? exhibit in a custom designed ?observatory? that he proposed could be housed on the waterfront in Liverpool in the Capital of Culture year, 2008. While this ambitious idea may be difficult to realise in its entirety, I would very much like to develop some aspects of this concept. In 2008, the BA annual meeting will be held in Liverpool. Significantly, the University of Liverpool Vice Chancellor, Professor Drummond Bone has just been appointed to the prestigious role of Chair of the City Culture Board (replacing Sir Bob Scott), demonstrating the increasingly close ties between the University and City in the planning of this important year.
Whenever milestones such as papers or important local meetings or events have been reached in our research, I have always worked with the University and other organisations in helping to generate good publicity. There was considerable local coverage of the formal opening of the Centre for Cell Imaging by Sir George Radda in 2003. The BBSRC have recently covered our Science paper on NF-kappaB oscillations in their BBSRC Business magazine and this and the accompanying press statement attracted international interest. I have helped several local charities with presentations to their local committees and at fund raising events.</gtr:abstractText><gtr:technicalSummary>We are applying novel multiparameter timelapse imaging technology in the Centre for Cell Imaging, to study the dynamics of signalling, transcription and cell fate. Through an MRC Career Establishment Grant, we showed that calcium signalling associated with fibroblast cell cycle entry regulates NF-kappaB-mediated activation of cyclin D1 (See et al., J. Cell Biol. 2004) We also characterized NF-kappaB as an oscillatory system (Nelson et al., Science, 2004). These discoveries provide novel insights into the mechanism of NF-kappaB control of transcription and cell fate, as well as its interactions with other signalling pathways. Our previous published work described the dynamics of two NF-kappaB proteins, RelA and IkappaBalpha, fused to fluorescent proteins. The NF-kappaB network involves more than 10 further proteins that form at least 4 negative feedback loops, with the potential to regulate the period and amplitude of NF-kappaB oscillations and thus to differentially regulate transcription. At least 3 of these (RelB, p100/p52 and p105/p50) give rise to distinct NF-kappaB signalling kinetics. We propose to define the integrated roles of the family of NF-kappaB proteins in cell lines and clinically relevant primary models to decipher their contribution to gene expression pathways leading to cell survival or cell division. Together with cell imaging, we will apply ChIP assays (with Mahadevan and Metivier) to study the kinetics of NF-kappaB binding to chromatin and transcription complex assembly. We will also study NF-kappaB binding in living cells (with Mancini).
Aims that we will investigate include: 1) The roles of NF-kappaB oscillations for transcription control. 2) The contribution of each NF-kappaB family member (A20 with Evans) to differential transcription. 3) The role of essential NF-kappaB protein modifications (mainly RelA) for oscillation dynamics and function? 4) Investigation of the mechanisms and consequences of cross-talk with other signalling pathways (calcium, glucocorticoid receptor (with Ray) and p53) for the regulation of cell fate. 5) How NF-kappaB responses vary in primary cells and pathological situations (neuroblastoma, with Losty and H. pylori-induced gastric cancer, with Dockray and Varro). This work will benefit from collaborations with scientists with complementary expertise (including mathematical modelling (Kell) and pharmaceutical drugs and assays (Unitt, AstraZeneca). 
The NF-kappaB pathway is now one of the most characterised examples of a protein-based signalling system that involves spatio-temporal oscillations that intimately control function. The development of a detailed dynamic analysis of this network promises to promote a paradigm-shift in the way that scientists think about signalling processes and cellular responses.</gtr:technicalSummary><gtr:fund><gtr:end>2009-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>476444</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Warwick</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with University of Warwick</gtr:description><gtr:id>DF3114F2-A9F9-4648-8026-2ADB42DEF473</gtr:id><gtr:impact>This multidisciplinary collaboration led to the award of the &amp;pound;5m BBSRC SABR grant between warwick, Liverpool and Manchester. This directly arose from this collaboration with the Warwick group assisting with the predictive modelling work. The collaboration supported the Science paper by Ashall et al., (19359585) In 2010 through more distantly related work, a &amp;pound;1.4m Wellcome trust Programme grant was awarded to Manchester and Warwick. In 2013 a further directly related &amp;pound;3.6m BBSRC sLOLA grant was awarded to Manchester and Warwick.</gtr:impact><gtr:outcomeId>ED54589CF72-1</gtr:outcomeId><gtr:partnerContribution>We have established a strong systems biology collaboration with the Systems Biology Department in Warwick (particularly with Prof. D. Rand). They have become our principal mathematics collaboration and contributed very significantly to our recent Science paper (Ashall et al.,) and other papers submitted or in preparation. This collaboration included the Warwick group (T. Brettschneider) using their own funds to assist us in the development of cell imaging programs through their employment of a post-doc. We also have collaborated over student training.</gtr:partnerContribution><gtr:piContribution>We have shared data and made visits to Warwick to discuss the collaboration.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Beatson Institute for Cancer Research</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Senectus Therapeutics</gtr:description><gtr:id>77CD87CF-C8BC-4DBB-95AC-051BDA5414F3</gtr:id><gtr:impact>IP and technology under development</gtr:impact><gtr:outcomeId>E2180DF545F-1</gtr:outcomeId><gtr:partnerContribution>Development of new awareness of drug screening and assay development and in senescence assays. This is a CRT discovery committee funded partnership to develop new assays and drugs to manipulate senescence in cancer cells. The project wasled by Glasgow, and also involved St Georges, CR-UK Institute Cambridge, and Horizon Technologies, Cambridge. The project wasfunded for 2 years, total funding ~&amp;pound;500k. M. White withdrew from direct involvement in 2010.</gtr:partnerContribution><gtr:piContribution>We provided experitise in fluorescence assays and live cell microscopy as well as in NF-kappaB signalling.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Manchester Interdisciplinary Biocentre</gtr:department><gtr:description>Collaboration with University of Manchester</gtr:description><gtr:id>46BE99E4-1D36-45E3-896A-1931AE9766D3</gtr:id><gtr:impact>This collaboration led to the award of the &amp;pound;5m BBSRC SABR grant between Warwick, Liverpool and Manchester. The collaboration supported the Science paper by Ashall et al., (19359585)
This ceased to be an external collaboration when M. White moved to Manchester University</gtr:impact><gtr:outcomeId>12887AE7A63-1</gtr:outcomeId><gtr:partnerContribution>Several staff from Manchester University collaborated in our application to BBSRC for a SABR initiative grant. Some of these staff had collaborated throughout the present MRC grant while others were new collaborators. Their contibutions were in nuclear structure and function, mathematics and databasing. (This collaboration 'ended' following the move of M. White from Liverpool to Manchester)</gtr:partnerContribution><gtr:piContribution>We have contributed ideas and data and we have recently transferred expertise for BAC expression technology to the Manchester group,</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Integrative Biology</gtr:department><gtr:description>Collaboration with University of Liverpool</gtr:description><gtr:id>E35706E0-7577-4D64-8BE5-670C174A25F8</gtr:id><gtr:impact>Multi-disciplinary - including mathematics, translational medicine and proteomics.</gtr:impact><gtr:outcomeId>jCAH5aMoVGg-1</gtr:outcomeId><gtr:partnerContribution>Contribution of data and intellectual input on shared BBSRC grant. Collaboration on student training. (This was a continuing collaboration following move of M. White from Liverpool to Manchester)</gtr:partnerContribution><gtr:piContribution>Contribution of data and intellectual input on shared BBSRC grant. Collaboration on student training.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with AstraZeneca</gtr:description><gtr:id>3B04D3D5-B698-4C5F-B289-2DA1BC1FB543</gtr:id><gtr:impact>Ashall et al (19359585)</gtr:impact><gtr:outcomeId>546380956A3-1</gtr:outcomeId><gtr:partnerContribution>We had a longstanding collaboration with AstraZeneca who advise on a number of projects and have made facilities and reagents available to us. As a result of this one AstraZeneca employee was a co-author on our Science paper by Ashall et al. (19359585). This collaboration closed following the closure of the AstraZeneca Charnwood site. Recently we have resetablished this collaboration and in the next few months a senior AstraZeneca employee plans to spend time in our lab learning imaging techniques.</gtr:partnerContribution><gtr:piContribution>We have discussed many aspects of our research with the staff from AstraZeneca, allowing them to help us to develop our research further. We also tested some candidate drugs. We have taken part in joint meetings and presented several seminars at AstraZeneca</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Talk at University of Tokyo (Mike White 2013)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5ACD772C-09D6-465A-83F3-8A84FA950019</gtr:id><gtr:impact>&amp;quot;NF-kB dynamics in primary cells and tissues: analysis of the role of frequency in NF-kB-dependent gene expression&amp;quot;

networking with other microscopy specialists, presentation of current work, training junior scientists, strengthening existing collaborations.</gtr:impact><gtr:outcomeId>q12jEAF6MdM</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at University of Tokyo (Dave Spiller 2012)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4A845259-4993-4600-A1D7-14DA1338F20A</gtr:id><gtr:impact>Dr Dave Spiller gave a talk at a mini-symposium, Professsor Ozawa's lab, University of Tokyo, Japan 12 December 2012.
&amp;quot;Quantitative analysis of dynamic protein interactions&amp;quot;

networking with other microscopy specialists, presentation of current work, training junior scientists, strengthening existing collaborations.</gtr:impact><gtr:outcomeId>ieUL1wAVzyb</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>talk at mini-symposium, Professsor Ohmiya's lab, University of Tsukuba,</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FE843D26-5FFA-492C-AD7D-7459FF266F55</gtr:id><gtr:impact>Dr Dave Spiller gave a talk at mini-symposium, Professsor Ohmiya's lab, University of Tsukuba, Japan 11 December 2012.

networking with other microscopy specialists, presentation of current work, training junior scientists, strengthening existing collaborations.</gtr:impact><gtr:outcomeId>pT9hnjZ9j6K</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar Talk (Leeds)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>5DCBB593-FCE6-42DD-B514-E3DB63364238</gtr:id><gtr:impact>Prof Mike White gave a seminar talk at the School of Molecular and Cellular Biology, University of Leeds, 23 October 2013.

networking with scientists, sharing ideas, presentation of current work.</gtr:impact><gtr:outcomeId>VeEQjXyDEjf</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited lecture at ASE annual conference 2008</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>FAF827BA-52DD-41C1-B837-B5B478AE8D81</gtr:id><gtr:impact>Lecture entitled &amp;quot;Visualising the language of cells&amp;quot;

Improved contacts with several schools</gtr:impact><gtr:outcomeId>717BDA8956D</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society Summer Exhibition (White, Spiller 2006)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E78A5944-63E1-41C1-A3CD-5422BF851053</gtr:id><gtr:impact>Exhibit entitled&amp;quot;The Language of Cells&amp;quot; presented at the Royal Society in July 2006 (just before this grant was started). The MRC project PI led the exhibiton team. This included explicit reference to treatment of disease. In association with this the Royal Society prepared a DVD that was widely distributed. Two members of our team took part in the video which was in part recorded in London and in part recorded at our labs in Liverpool. We chose two younger women for this so that they could talk about scientific careers for women. One of the featured staff was Dr Dhanya Mullassery, who soon after became an MRC Clinical Research Training Fellow.

The Royal Society and the University of Liverpool prepared a Press release associated with this activity. MW gave several interviews with the press Considerably increased contacts with schools and other scientists The Royal Society later prepared a DVD that was widely distributed. Two members of our team took part in the video which was in part recorded in London and in part recorded by a visit of the film team to our labs in Liverpool. We chose two younger women to be featured in this, so that they could also talk about scientific careers for women. One of the featured staff was Dr Dhanya Mullassery, who soon after became an MRC Clinical Research Training Fellow.</gtr:impact><gtr:outcomeId>6DA40ED3A9D</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar in Southampton (White 2013)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>641D94F3-006C-4FB8-8418-BDBCA86E7CB2</gtr:id><gtr:impact>Seminar at Endocrinology, Nutrition &amp;amp; Metabolism' seminar, University of Southampton, 26th March 2013.

networking with scientists, sharing ideas, presentation of current work, training for junior staff and students.</gtr:impact><gtr:outcomeId>tZn9MpAT8vE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at Frontiers in Bioimaging, London (White 2013)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>AADE66F9-BD4F-4F4D-93FE-420460CB84A7</gtr:id><gtr:impact>Prof Mike White:Invited speaker at Frontiers in Bioimaging, London, 3-4 July 2013.

networking with national scientists, sharing ideas, presentation of current work, influencing microscopy practitioners.</gtr:impact><gtr:outcomeId>NX3KmkCSeTS</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.rms.org.uk/events/Forthcoming_Events/frontiersinbioimaging</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at EMBO Course, Kings College London (Papalopulu 2013)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D55E8545-7C29-4969-AC61-E46559D1BC6A</gtr:id><gtr:impact>Professor Nancy Papalopulu: EMBO course on Developmental Neurobiology, KCL, July 2013

Training session for postgrads and post-docs, practical demonstrations.</gtr:impact><gtr:outcomeId>aeVsxUWSk1p</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:url>http://events.embo.org/13-dev-neuro/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at Mini-symposium,AIST, Japan (White 2012)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D5D35CA2-CDA9-4470-91DB-2325B1ADB153</gtr:id><gtr:impact>Mini-symposium,AIST, Japan 11 December 2012 on luciferase technology.

networking with international scientists and sharing of ideas.</gtr:impact><gtr:outcomeId>eyzCRBVtxmQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Publicity for research through BBSRC and MRC (White)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>486006E9-C584-4656-B68E-C8BA585A6C4B</gtr:id><gtr:impact>Publicity for recent research through BBSRC business. This involved publicity following award of BBSRC SABR programme grant and after publication of the Science paper by Ashall et al. In early 2010 BBSRC are publishing a feature article about our interdisciplinary research in BBSRC business.

Press releases and widespread publicity for the research following the award of the BBSRC SABR grant and the publication of the Ashall et al., paper in Science. The MRC participated in this press release.</gtr:impact><gtr:outcomeId>E5B0E6C59A9</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article for The Endocrinologist (White 2009)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>81FB52EE-5764-49F4-A342-0DF7FF4F416B</gtr:id><gtr:impact>The MRC project PI wrote an article for The Endocrinologist (winter 2009 edition) entitled &amp;quot;Predicting a future for systems biology&amp;quot;. This was requested in order to publicise a session at the BES2010 meeting which is planned in order to publicise awareness of the field. see http://www.endocrinology.org/endocrinologist/094/094.pdf#page=13

Nothing yet. The aim was to publicise the session at the spring meeting.</gtr:impact><gtr:outcomeId>38C2ED44023</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Buckingham Palace science Day (White, Spiller 2006)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F553E373-9F6F-4BFA-B285-53930A310669</gtr:id><gtr:impact>Exhibit entitled &amp;quot;the Language of cells&amp;quot; presented at Science Day at Buckingham Palace in October 2006. This was attended by schools, leading scientists and several membersof the royal family including The Queen and Prince Philip.

A press release was prepared by The Royal Society and th University of Liverpool and there was considerable publicity.</gtr:impact><gtr:outcomeId>088A4F6E0A0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Glasgow Science festival (White 2006)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>98838AFA-8416-4F3B-943B-976CD08F3D1A</gtr:id><gtr:impact>Exhibit entitled&amp;quot;The Language of Cells&amp;quot; presented in Glasgow in September 2006 . The MRC project PI led the exhibiton team. This included explicit reference to treatment of disease.

Considerably increased contacts with schools and other scientists</gtr:impact><gtr:outcomeId>A11246F85EA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at Prof Kuroda's Systems Biology Lab, Tokyo (White 2013)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>48995749-3AFE-4BCC-BD24-D4E3E925D715</gtr:id><gtr:impact>Prof White gave a seminar talk at Prof Kuroda's Systems Biology Lab, Tokyo, Japan, November 2013. Mike White talking on protein interactions, photo-activatable proteins and systems biology.

Strengthening collaborations in Japan and networking with scientists and technicians, sharing ideas, presentation of current work.</gtr:impact><gtr:outcomeId>eEdi5GLwV39</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at Prof Kuroda's Systems Biology Lab, Tokyo, Japan (Spiller 2013)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>09759C9C-484C-4557-AC86-F9595071FBF7</gtr:id><gtr:impact>Dr Dave Spiller gave a seminar talk at Prof Kuroda's Systems Biology Lab, Tokyo Japan, 1st November 2013. &amp;quot;Measuring the interactions of NF-kappaB proteins inside living cells&amp;quot;

Strengthening collaborations in Japan and networking with scientists and technicians, sharing ideas, presentation of current work</gtr:impact><gtr:outcomeId>KiWHu4qNLWk</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar Talk,Bath (White 2013)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>99097E77-86F0-4C85-AE0A-B4DF9ECBEBB0</gtr:id><gtr:impact>Prof Mike White gave a seminar talk at Department of Biology and Biochemistry, University of Bath, 30 March 2013.

networking with national scientists, sharing ideas, presentation of current work, education/training for junior staff and students.</gtr:impact><gtr:outcomeId>XG2ag8yiL2x</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at  &quot;Non-genetic heterogeneity&quot; Workshop, FLS, Manchester (White 2013)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>ABB28C6A-1AB1-4E01-B0CE-6B2633DDC7B3</gtr:id><gtr:impact>Prof Mike White gave a presentation at University of Manchester, Faculty of Life Sciences Workshop, Hosted by Molecular Cancer Studies &amp;quot;Non-genetic heterogeneity&amp;quot;, 18th February 2013.

networking with colleagues, sharing ideas, presentation of current work, training for more junior staff members.</gtr:impact><gtr:outcomeId>X2KEygYqW52</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>4160524</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Strategic Lola</gtr:description><gtr:end>2018-04-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef> BB/K003097/1</gtr:fundingRef><gtr:id>27298881-5B26-4FAD-BE1F-F1715FCA2848</gtr:id><gtr:outcomeId>Xdp7TFUFPEq</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>630089</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Project Grant (A systems biology study of E2F and NF-kappaB cross-talk)</gtr:description><gtr:end>2013-01-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/H103725/2</gtr:fundingRef><gtr:id>2EE21394-EEA8-4184-8816-51AF25DE5654</gtr:id><gtr:outcomeId>CmNDeMr5qaH0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2583208</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>(W Muller, MW, D Jackson, S Schreiber, T Hofer, D Rand, C Troutwein, J Rhodes, M Pierik, N Schpigel, VM dos Santos, A Kel, L Ferguson, B Fuchs). Systems medicine of chronic inflammatory bowel disease.</gtr:description><gtr:end>2017-11-02</gtr:end><gtr:fundingOrg>Systems Medicine of Chronic Inflammatory Bowel Disease</gtr:fundingOrg><gtr:fundingRef>305564</gtr:fundingRef><gtr:id>F3B17A39-7FAD-4E31-BE8F-4C81CCDB26DC</gtr:id><gtr:outcomeId>SDstkynAguV</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>218114</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical Research Training Fellowship</gtr:description><gtr:end>2009-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>E965212D-088B-4139-B787-2B8D44C75C30</gtr:id><gtr:outcomeId>B85DDE465F80</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1273491</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Imaging of cellular dynamics from single molecules to tissues.</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/K015885/1</gtr:fundingRef><gtr:id>004B8D8B-DD83-429A-AD71-3AB94C0DDC60</gtr:id><gtr:outcomeId>okNBrRi1m1o</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRT Discovery committee</gtr:description><gtr:end>2009-07-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>870986EA-EB5A-4D8F-B98D-F07AE97E7ACA</gtr:id><gtr:outcomeId>44F84DAA5CC0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5072010</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Dynamics and function of the NF-?B signalling system</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/F005938/2</gtr:fundingRef><gtr:id>0EBB55C8-BA45-474C-9B12-C83D9DBBC0EC</gtr:id><gtr:outcomeId>53db7887747779.89331202</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>946737</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC David Phillips Fellowship to Pawel Paszek</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>C307499E-A3BB-4194-814C-5C19ACE57B8C</gtr:id><gtr:outcomeId>QDzFwi2Tpag0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4900000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Capital clinical infrastructure for single cell genomics</gtr:description><gtr:end>2020-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>32FA9C59-BF87-48CA-A5D2-A46D2A47B4B7</gtr:id><gtr:outcomeId>5463efeacfb7b2.83507258</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>31026</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Japanese Partnering Award</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/G530276/2</gtr:fundingRef><gtr:id>DFB906AC-FFBB-46D2-8E47-FA684F701EA5</gtr:id><gtr:outcomeId>pcKypEwga1c0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of MRC Population and System Medicine Board, 1 April 2012 - 1 April 2016</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9397D89D-A33C-40DE-9DD6-43A54311907E</gtr:id><gtr:outcomeId>GPvJF3EsqEr</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of BBSRC Research Equipment Initiative (REI) Review Panel</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>32D3D47B-8AD8-4DDF-99AF-BCBF02C7707B</gtr:id><gtr:outcomeId>LaFbgzKTd7U</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>German Virtual Liver Scientific Advisory Board (42m euros programme )</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>3551586F-F904-466D-80A0-6AA93EA4EB79</gtr:id><gtr:outcomeId>SQ6EWWziHpg</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.virtual-liver.de/wordpress/en/media/handling-biological-complexity-using-systems-approaches-4/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Membership of BBSRC Interdisciplinary Systems Biology Strategy Committee</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>530DA309-B3C7-4833-BCC4-97238F237512</gtr:id><gtr:outcomeId>76DBBCB53BF</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of BBSRC Site visit to Oxford Centre for Systems Biology</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0BFD80B5-60A7-407C-9458-D4D232B44CFB</gtr:id><gtr:outcomeId>dLQuSozmxAs</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of BBSRC Site visit to Imperial Centre for Systems Biology</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>966163FC-BFB0-46CF-9EC4-0564DD600518</gtr:id><gtr:outcomeId>JbZCKGpR49Z</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BBSRC Panel: Enabling Theme 2, the Exploiting New Ways of Working Strategy Panel (ENWW)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C70C3B39-037E-448B-836C-429B8D9E3CC3</gtr:id><gtr:outcomeId>riBfcac3je2</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>External Reviewer for FRISYS-ZBSA (Zentrum fur biosystemanalyse), Freiberg, Germany, 26th May 2011.</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>4D5C0E83-C6EC-4A12-BAB0-8D028BCD02AF</gtr:id><gtr:outcomeId>CMtJqz47g26</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Appointed to Pool of Experts for BBSRC Panels, 2012-2013.</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>526888F3-1B75-4EA1-A375-905581228087</gtr:id><gtr:outcomeId>rgc51j4k6oZ</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BBSRC Strategic Tools and Resources Development Fund (sTRDF) Panel</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>540C3A15-785C-4139-A731-FDB871BD3C1B</gtr:id><gtr:outcomeId>Qzw98FM5zsM</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC Microbiome</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9660E555-9A3F-4F96-B671-0DD902E59160</gtr:id><gtr:outcomeId>UHVaTGTTYuh</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BBSRC Bioscience for Industry Committee (single meeting for presentation)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>811C93C6-3680-4B9E-B1E0-5E5403D2BA00</gtr:id><gtr:outcomeId>H3Sci3mDtx1</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of BBSRC Tools and Resources Development Fund Panel, Feb 2012.</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B9B29FC6-8779-4CE0-A3EE-EABB263134F8</gtr:id><gtr:outcomeId>tLZAjo7VmqU</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC Systems Immunology</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FD501118-42B2-4C87-88F5-A297382E0145</gtr:id><gtr:outcomeId>ikEgUKbYUuJ</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Invited to attend Research Sponsors' Consultation Meeting (BBSRC &amp;amp;MRC) on Imaging for the biological and biomedical sciences, 14 May 2012.</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6162F696-50BA-4C10-B011-631BBC181BDE</gtr:id><gtr:outcomeId>Vi7N2FEHYfR</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC/BBSRC New Microscopy Initiative</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>77C19469-3C05-49D8-ADC4-C40E8B533F3E</gtr:id><gtr:outcomeId>E7iSQ5JAkkZ</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Wellcome Trust/Wolfson Capital Awards in Biomedical Sciences Committee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>08565BBE-9DFE-430C-BAFB-9B8FDA46AABD</gtr:id><gtr:outcomeId>RPPFikr7KT7</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of BBSRC/EPSRC TDRI Panel</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5053B811-0F49-4382-8CA5-249552521C3A</gtr:id><gtr:outcomeId>Xms5gDPEt91</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of MRC Doctoral Training Panel</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>ACB023E5-92A9-40A3-91E3-9BDD7C1124E4</gtr:id><gtr:outcomeId>E5DDLDFEd7s</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>ODE and stochastic models of the NF-kB system and other modules that couple with it</gtr:description><gtr:id>33A810C8-B5D3-4BD9-BAFE-D6C54AF968A2</gtr:id><gtr:impact>Multiple citations with other papers being based on our models</gtr:impact><gtr:outcomeId>546414c786e496.74406010</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Mathematical models of NF-kB and inked systems</gtr:title><gtr:type>Computer model/algorithm</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Models that have bee n published have been made available online. see http://www.liv.ac.uk/bio/research/groups/cci/</gtr:description><gtr:id>B67398FF-09A2-4298-B445-56A02F13E7FD</gtr:id><gtr:impact>There has been substantial interest in these models.</gtr:impact><gtr:outcomeId>BECE511256B</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Mathematical models of the NF-kappaB signalling pathway</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have made bacterial artificial chromosomes expressing most of the key NF-kappaB proteins fused to fluorescent proteins. Cell lines have been made from several of these.</gtr:description><gtr:id>0AD40CFC-595E-4E71-B5AD-72D3EAA43380</gtr:id><gtr:impact>These have been used to make stable cell lines and more recently IkBalpha-EGFP and p65-DsRed expressing transgenic mouse lines. Initial data suggests that these will be extremely powerful research tools.</gtr:impact><gtr:outcomeId>JkzvWTvJA6c</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Bacterial Artificial Chromosomes</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Plasmids which have been published have been made abailable to other researchers. We have made plasmids and cell lines available when published.</gtr:description><gtr:id>A0796219-717A-4E26-92FA-3CDB02910DEF</gtr:id><gtr:impact>We now regularly receive a large number of requests for plasmids and some requests for a cell line that relates to this work. These plasmids have been used for the construction of bacterial artificial chromosomes (which are as yet unpublished). These are now being used to construct transgenic animals</gtr:impact><gtr:outcomeId>A4C8339BF9C</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>NF-kappaB protein expression plasmids</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Senectus Therapeutics</gtr:companyName><gtr:description>This is a company designed to hold IP from a CRUK funded project established by the CRT Discovery committee. The focus is on assays and drug discovery for manipulation of cancer cell senescence.; http://www.senectustherapeutics.com/</gtr:description><gtr:id>A8752A9E-EDBD-4947-BDE5-6CFB1F1E8354</gtr:id><gtr:impact>This is at an early stage. IP is being established. In 2011 I ceased major involvement, although Liverpool University retains an interest.</gtr:impact><gtr:outcomeId>B7D250A3498</gtr:outcomeId><gtr:yearCompanyFormed>2009</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>8BD9E2C6-48D5-4261-BE35-A886136F89C5</gtr:id><gtr:title>Systems biologists seek fuller integration of systems biology approaches in new cancer research programs.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f3fae87ae416592d00b5919e369ca46"><gtr:id>1f3fae87ae416592d00b5919e369ca46</gtr:id><gtr:otherNames>Wolkenhauer O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>pm_14397_27_20028868</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA632AB8-9A99-4B61-AD56-510E5A6A0C20</gtr:id><gtr:title>Physiological levels of TNFalpha stimulation induce stochastic dynamics of NF-kappaB responses in single living cells.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f5401e07b1f28cc26f50d770bb42e18"><gtr:id>9f5401e07b1f28cc26f50d770bb42e18</gtr:id><gtr:otherNames>Turner DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>E7GPhwHFZAr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F28AC8E7-FA4D-4165-9678-A7C6CBAF9355</gtr:id><gtr:title>Tumor necrosis factor-alpha activates the human prolactin gene promoter via nuclear factor-kappaB signaling.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd3f1f24335d1335a47b7dadc2a228c3"><gtr:id>bd3f1f24335d1335a47b7dadc2a228c3</gtr:id><gtr:otherNames>Friedrichsen S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>56dd4376610196.93786641</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46986592-96D5-4B03-B82F-4DD10B3DA49C</gtr:id><gtr:title>Measurement of single-cell dynamics.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16dd1bc3a81880422ff91e01ec156a56"><gtr:id>16dd1bc3a81880422ff91e01ec156a56</gtr:id><gtr:otherNames>Spiller DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>BFfHFELQHzo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>890DBE9A-603A-4741-879D-770A0D5E7391</gtr:id><gtr:title>Human prolactin gene promoter regulation by estrogen: convergence with tumor necrosis factor-alpha signaling.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0d35dd83da1d17b8a4d9b8523031197"><gtr:id>a0d35dd83da1d17b8a4d9b8523031197</gtr:id><gtr:otherNames>Adamson AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>56dd43758ae5a4.22250267</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>723C53FF-E943-4D22-94B1-72B17F7E7EAC</gtr:id><gtr:title>Automated tracking of gene expression in individual cells and cell compartments.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society, Interface</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/796250a91390a6d962eff2a2a8a0b47a"><gtr:id>796250a91390a6d962eff2a2a8a0b47a</gtr:id><gtr:otherNames>Shen H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1742-5662</gtr:issn><gtr:outcomeId>56dd4376ddf9e5.08149460</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFDA7371-8A6B-4FE8-9930-60F7CC9EA751</gtr:id><gtr:title>NF kappa B inhibitors promote cell death in both S and N type neuroblastoma cell lines</gtr:title><gtr:parentPublicationTitle>PEDIATRIC BLOOD &amp; CANCER</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a514aadd6b1d05061f2e92d553b7483b"><gtr:id>a514aadd6b1d05061f2e92d553b7483b</gtr:id><gtr:otherNames>Mullasserv Dhanva</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1545-5009</gtr:issn><gtr:outcomeId>56dd437de976d0.54178423</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18D1B8F3-0048-4B9B-82BE-A2F20CEF5955</gtr:id><gtr:title>Dynamic NF-?B and E2F interactions control the priority and timing of inflammatory signalling and cell proliferation.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0e38be90a63e0284f712d735e9d2194"><gtr:id>e0e38be90a63e0284f712d735e9d2194</gtr:id><gtr:otherNames>Ankers JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>585d4083671c36.52082726</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF9C3284-4355-48BA-96D1-A6B8B2C75DBE</gtr:id><gtr:title>Single-cell time-lapse imaging of the dynamic control of NF-kappa B signalling</gtr:title><gtr:parentPublicationTitle>BIOCHEMICAL SOCIETY TRANSACTIONS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d1cbe5856fa6ae96b59a6bc1733a11c"><gtr:id>7d1cbe5856fa6ae96b59a6bc1733a11c</gtr:id><gtr:otherNames>Sillitoe K.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>56dd437dc38b69.65517106</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>615E786C-E143-42CF-A579-DC05BACFEAE7</gtr:id><gtr:title>Population robustness arising from cellular heterogeneity.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43306b88df69e9ecc9c8641a7535e180"><gtr:id>43306b88df69e9ecc9c8641a7535e180</gtr:id><gtr:otherNames>Paszek P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>435BAB39814</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DBED6BA-AF9E-4896-818C-8613C91E192F</gtr:id><gtr:title>Interactions among oscillatory pathways in NF-kappa B signaling.</gtr:title><gtr:parentPublicationTitle>BMC systems biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52542eaf317f347220ec706e5b20b4a1"><gtr:id>52542eaf317f347220ec706e5b20b4a1</gtr:id><gtr:otherNames>Wang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1752-0509</gtr:issn><gtr:outcomeId>pm_14397_27_21291535</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6ADDF047-0ED1-45D8-994B-9951BA1784E5</gtr:id><gtr:title>Single-cell time-lapse imaging of the dynamic control of NF-kappaB signalling.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f0699fa766bde0866b71bb9d0c10b95"><gtr:id>4f0699fa766bde0866b71bb9d0c10b95</gtr:id><gtr:otherNames>Sillitoe K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>pm_5435aa25aa2684513</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13AA6E24-2651-4F0E-84F3-3CAE9DBB1C45</gtr:id><gtr:title>Spatio-temporal protein dynamics in single living cells.</gtr:title><gtr:parentPublicationTitle>Current opinion in biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0e38be90a63e0284f712d735e9d2194"><gtr:id>e0e38be90a63e0284f712d735e9d2194</gtr:id><gtr:otherNames>Ankers JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0958-1669</gtr:issn><gtr:outcomeId>pm_5435aa25aa25f0658</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F4B8830-99CB-4DEB-9F47-5BDA7CCF635D</gtr:id><gtr:title>Single live-cell imaging for systems biology.</gtr:title><gtr:parentPublicationTitle>Essays in biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ac63894ccb781329b1b5aab30dd2fd7"><gtr:id>9ac63894ccb781329b1b5aab30dd2fd7</gtr:id><gtr:otherNames>Mullassery D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0071-1365</gtr:issn><gtr:outcomeId>7D69D0435ED</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C526BC9B-DCA2-4BAC-AE60-EE34669FDFFA</gtr:id><gtr:title>Understanding the dynamics of Toll-like Receptor 5 response to flagellin and its regulation by estradiol.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03e3f281f991842a94363c7902ec5bee"><gtr:id>03e3f281f991842a94363c7902ec5bee</gtr:id><gtr:otherNames>Caballero I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58c933a839d9a2.20600805</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E2C1B05-2455-49D5-BC89-225282711264</gtr:id><gtr:title>Predicting the points of interaction of small molecules in the NF-?B pathway.</gtr:title><gtr:parentPublicationTitle>BMC systems biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8766afa6a4f20ca9202f47f25c579167"><gtr:id>8766afa6a4f20ca9202f47f25c579167</gtr:id><gtr:otherNames>Patel Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1752-0509</gtr:issn><gtr:outcomeId>doi_14397__0509_5_32</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF67958B-2A50-4AD7-9791-C0394C7DBCF9</gtr:id><gtr:title>Signal transduction controls heterogeneous NF-?B dynamics and target gene expression through cytokine-specific refractory states.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dba0d2441f6590a38f374dcb1bc49357"><gtr:id>dba0d2441f6590a38f374dcb1bc49357</gtr:id><gtr:otherNames>Adamson A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>585d4095207655.83986261</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC78D556-E313-4D27-AED0-AF2B6C7410E0</gtr:id><gtr:title>Quantitative measurement of single cell dynamics.</gtr:title><gtr:parentPublicationTitle>Current opinion in biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a46ae951fd0e594cba8c3885122941d7"><gtr:id>a46ae951fd0e594cba8c3885122941d7</gtr:id><gtr:otherNames>Bakstad D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0958-1669</gtr:issn><gtr:outcomeId>pm_5435ad15ad18e64ad</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44C1566E-44DA-4234-962B-15585580B8E0</gtr:id><gtr:title>Pulsatile stimulation determines timing and specificity of NF-kappaB-dependent transcription.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3077f1b65f77d947c9d66332a83db2e"><gtr:id>a3077f1b65f77d947c9d66332a83db2e</gtr:id><gtr:otherNames>Ashall L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>DC12DC4A294</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EADDA0BA-52D2-44F5-8657-83148D3D036D</gtr:id><gtr:title>Is frequency-encoding of information a major theme in cellular processes?</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2bcfcdf6466787612399f95b8c49476"><gtr:id>c2bcfcdf6466787612399f95b8c49476</gtr:id><gtr:otherNames>White MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>m_38261930091398bfa8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBF050B1-6539-40EC-BA04-618C0D026AF6</gtr:id><gtr:title>Spatial and temporal information coding and noise in the NF-?B system.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/683755542bb83177f257ed8c9a4c6dce"><gtr:id>683755542bb83177f257ed8c9a4c6dce</gtr:id><gtr:otherNames>Marcello M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>pm_540e140e140802673</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E63F5A9A-E78B-400D-A58E-A532BE01EA94</gtr:id><gtr:title>Automatic tracking of biological cells and compartments using particle filters and active contours</gtr:title><gtr:parentPublicationTitle>Chemometrics and Intelligent Laboratory Systems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/796250a91390a6d962eff2a2a8a0b47a"><gtr:id>796250a91390a6d962eff2a2a8a0b47a</gtr:id><gtr:otherNames>Shen H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:outcomeId>56dd4376c04a80.54139972</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8706E717-3000-4356-A35F-C1327689CEAA</gtr:id><gtr:title>Oscillatory control of signalling molecules.</gtr:title><gtr:parentPublicationTitle>Current opinion in genetics &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43306b88df69e9ecc9c8641a7535e180"><gtr:id>43306b88df69e9ecc9c8641a7535e180</gtr:id><gtr:otherNames>Paszek P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-437X</gtr:issn><gtr:outcomeId>pm_5435ad15ad13bef74</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>670E5AAC-175C-467F-84FC-8AA1FCF5DCCB</gtr:id><gtr:title>A systematic survey of the response of a model NF-?B signalling pathway to TNFa stimulation.</gtr:title><gtr:parentPublicationTitle>Journal of theoretical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52542eaf317f347220ec706e5b20b4a1"><gtr:id>52542eaf317f347220ec706e5b20b4a1</gtr:id><gtr:otherNames>Wang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-5193</gtr:issn><gtr:outcomeId>doi_55f983983a95f34f</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500346</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>80</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>